0

Talampanel

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP161832651
CAS161832-65-1
Structure
MDL NumberMFCD00871406
Molecular Weight337.37
InChI KeyJACAAXNEHGBPOQ-LLVKDONJSA-N
Description≥97% (HPLC)
SolubilityDMSO: 15 mg/mL, clear
Assay≥97% (HPLC)
Colorwhite to beige
Formpowder
SizePricing&availabilityisnotcurrentlyavailable.
Storage Conditions2-8°C
1

A Phase II Trial of Talampanel in Subjects With Amyotrophic Lateral Sclerosis

Robert M Pascuzzi, Jeremy Shefner, Amy S Chappell, John S Bjerke, Roy Tamura, Vinay Chaudhry, Lora Clawson, Lisa Haas, Jeffrey D Rothstein

Amyotroph Lateral Scler. 2010 May 3;11(3):266-71.

PMID: 19961264

1

Amyotrophic Lateral Sclerosis

Klara Valko, Lukasz Ciesla

Prog Med Chem. 2019;58:63-117.

PMID: 30879475

1

Mechanism of Inhibition of the GluA2 AMPA Receptor Channel Opening by Talampanel and Its Enantiomer: The Stereochemistry of the 4-methyl Group on the Diazepine Ring of 2,3-benzodiazepine Derivatives

Congzhou Wang, Li Niu

ACS Chem Neurosci. 2013 Apr 17;4(4):635-44.

PMID: 23402301

1

Pre- And Post-Exposure Talampanel (GYKI 53773) Against Kainic Acid Seizures in Neonatal Rats

Ashish Dhir, Vishal Chavda

Pharmacol Rep. 2016 Feb;68(1):190-5.

PMID: 26721372

1

Talampanel

John F Howes, Cynthia Bell

Neurotherapeutics. 2007 Jan;4(1):126-9.

PMID: 17199027

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode